Table 2.
Univariate Comparison between Patients with and without VTE among Those with D-Dimer levels ≥10.0 μg/mL.
| Variables | VTE(+) (n = 31) | VTE(−) (n = 312) | p-Value |
|---|---|---|---|
| Sex: female, n (%) | 29 (93.5) | 281 (90.1) | 0.53* |
| Age (years), mean | 67.8 | 66.0 | 0.33** |
| BMI (kg/m2), mean | 23.5 | 23.0 | 0.66** |
| Diabetes treatment, n (%) | 3 (9.7) | 45 (14.4) | 0.47* |
| ASA-PS ≥3, n (%) | 2 (6.5) | 14 (4.5) | 0.62* |
| Intraoperative blood loss (g/body weight 50 kg), mean | 486.0 | 436.0 | 0.38** |
| No edoxaban use, n (%) | 12 (38.7) | 58 (18.6) | 0.008* |
| D-dimer level at 1 week (μg /mL), mean | 17.1 | 13.0 | <0.001** |
*Chi-square test; **Welch’s t test.
ASA-PS: American Society of Anesthesiologists Physical Status; BMI: body mass index; VTE: venous thromboembolism.